CD155 contributes to the mesenchymal phenotype of triple‐negative breast cancer

Patients with triple‐negative breast cancer (TNBC) lack molecular targets and have an unfavorable outcome. CD155 is overexpressed in human cancers, but whether it plays a role in TNBC is unexplored. Here we found that CD155 was enriched in both TNBC cell lines and tumor tissues. High CD155 expressio...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Qianqian, Gao, Jian, Yin, Ping, Wang, Wei, Wang, Biao, Li, Yan, Zhao, Chenghai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004517/
https://www.ncbi.nlm.nih.gov/pubmed/31830330
http://dx.doi.org/10.1111/cas.14276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004517/
https://www.ncbi.nlm.nih.gov/pubmed/31830330
http://dx.doi.org/10.1111/cas.14276

Ejemplares similares